2nd Quarter - Report
TIBER CREEK GROUP for ASTRAZENECA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.27, Preserve Access to Affordable Generics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Health Issues HCR
Medicaid Drug Rebates. Reforms to Medicare Part D. S.27, Preserve Access to Affordable Generics Act. S. 3187, the Food and Drug Administration Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Medicare/Medicaid MMM
Medicaid Drug Rebates. Reforms to Medicare Part D. S.1251, Medicare and Medicaid FAST Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Pharmacy PHA
S.27, Preserve Access to Affordable Generics Act. Reauthorization of the Prescription Drug User Fee Act. S. 1734, Generating Antibiotic Incentives Now Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.